Skip to content

CVCT CardioBrief

  • Home
  • About
    • Mission
  • CVCT Forum
  • Cardiobrief Archive
  • FAQ
  • Contact
  • Privacy Policy
  • Cookies Policy
  • Terms of use
search
search
February 12, 2021

The First Truly Effective Weight Loss Drug Arrives

By : Alexandra Nowbar

It looks like the first truly effective weight loss drug has arrived. Learn the basic facts about semaglutide and get perspectives from Milton Packer and Sanjay Kaul on what lies ahead.

February 06, 20212021-02-04T17:15:19-05:00

Trials in Heart Failure with Preserved Ejection Fraction: An Interview with Steve Nissen and Milton Packer

By : Alexandra Nowbar

Faiez Zannad moderates a fascinating discussion between Milton Packer and Steve Nissen about the PARAGON-HF trial in heart failure with preserved ejection fraction. Nissen was…

February 05, 20212021-02-04T17:12:25-05:00

Outtake from the Steve Nissen and Milton Packer discussion about PARAGON and TOPCAT moderated by Faiez Zannad

By : Alexandra Nowbar
February 05, 20212021-02-04T17:13:00-05:00

A Brand New Drug for Heart Failure with Reduced Ejection Fraction: An Interview with Javed Butler about Vericiguat

By : Alexandra Nowbar

Faiez Zannad speaks to Javed Butler about the FDA approval of new drug, vericiguat, for heart failure with reduced ejection fraction, following the publication of…

February 04, 2021

Global Trials Summit 2021: An Interview with John McMurray

By : Alexandra Nowbar

Faiez Zannad speaks to John McMurray about the Global Trials Summit being held virtually on 12th and 13th February 2021. Register here : https://global-trials-summit.hubilo.com/

December 30, 20202021-01-02T10:19:45-05:00

Chunkification of Clinical Trials: Why aren’t we adopting the Win Ratio more widely?

By : Alexandra Nowbar

Most of us like our news (medical or otherwise) pre-digested into understandable chunks for consumption. This need for this is inevitable because we expect to…

December 11, 20202021-01-03T09:00:02-05:00

CVCT Forum 2020: An Interview with John Teerlink about Omecamtiv

By : Alexandra Nowbar

What’s unique about omecamtiv? Darrel Francis speaks to GALACTIC-HF PI, John Teerlink about that dirty word in heart failure… “inotrope”. The new language is myotropes,…

December 08, 2020

CVCT Forum 2020: An Interview with Paul Armstrong about Vericiguat

By : Alexandra Nowbar

Darrel Francis speaks to Paul Armstrong, PI of the VICTORIA trial, about the mechanism of new heart failure drug, Vericiguat, and the trial’s unusual power calculation: “The trial was deliberately overpowered on the primary endpoint”.

December 06, 2020

Charlie and the Medicine Factory (Do we really need to understand mechanisms?)

By : Angry Cardiologist

One of my favorite books growing up was “Charlie and the Chocolate Factory”. I revelled in the comeuppance meted out to the likes of Augustus…

November 29, 20202020-11-28T11:07:39-05:00

CVCT Forum Teaser 2020: SGLT2 inhibitor trials in CKD

By : Pauline Lavigne

SGLT2 inhibitors are probably the hottest new drug on the scene in cardiology this year. They were bandied about for lowering glucose in diabetes but…

Posts navigation

1 2 Next

Subscribe to Blog via Email

Enter your email address to subscribe to this blog and receive notifications of new posts by email.

Join 241 other subscribers

  • Contact
  • Privacy Policy
  • Cookies Policy
  • Terms of use
  • Contact
  • Privacy Policy
  • Cookies Policy
  • Terms of use